Statin Therapy Is Not Associated with Improved Vascular Access Outcomes | Zendy

Roberto Pisoni | Zendy; Jill Barker-Finkel | Zendy; Michael Allo | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Statin Therapy Is Not Associated with Improved Vascular Access Outcomes

Author(s) -

Roberto Pisoni,

Jill Barker-Finkel,

Michael Allo

Publication year - 2010

Publication title -

clinical journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.755

H-Index - 151

eISSN - 1555-905X

pISSN - 1555-9041

DOI - 10.2215/cjn.02740310

Subject(s) - medicine , hazard ratio , statin , hemodialysis , dialysis , surgery , diabetes mellitus , coronary artery disease , proportional hazards model , cardiology , confidence interval , endocrinology

Neointimal hyperplasia is the major cause of vascular access failure in hemodialysis patients. Statins reduce neointimal hyperplasia in experimental models, which may reduce access failure. The study presented here evaluated whether vascular access outcomes are superior in patients receiving statin therapy than in those not on statins.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research